World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
70
Citations
11574
World Ranking
7191
National Ranking
29

Jang Yang Chang publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Jang Yang Chang sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 277 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Jang Yang Chang D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Jang Yang Chang sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 70 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Enzyme

Jang Yang Chang mostly deals with Stereochemistry, Cancer research, Cancer, Cell culture and Biochemistry. His Stereochemistry study incorporates themes from IC50, In vitro, Chemical synthesis, Cytotoxicity and Combretastatin. His Cancer research research is multidisciplinary, incorporating elements of DNA damage, Carcinogenesis, Apoptosis, microRNA and Regulation of gene expression.

He is studying Cancer cell, which is a component of Cancer. His Cell culture research incorporates elements of Mitosis and Cell growth. The study of Biochemistry is intertwined with the study of Tubulin in a number of ways.

His most cited work include:

  • BPR0L075, a Novel Synthetic Indole Compound with Antimitotic Activity in Human Cancer Cells, Exerts Effective Antitumoral Activity in Vivo (174 citations)
  • BPR0L075, a Novel Synthetic Indole Compound with Antimitotic Activity in Human Cancer Cells, Exerts Effective Antitumoral Activity in Vivo (174 citations)
  • Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents. (147 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Cancer research, Internal medicine, Cancer, Cancer cell and Stereochemistry. His studies in Cancer research integrate themes in fields like Cell growth, Carcinogenesis, Apoptosis, Downregulation and upregulation and microRNA. His research investigates the connection between Internal medicine and topics such as Oncology that intersect with problems in Chemotherapy.

Jang Yang Chang interconnects Cell and Cell biology in the investigation of issues within Cancer cell. His study in Stereochemistry is interdisciplinary in nature, drawing from both Cell culture, In vitro, Structure–activity relationship, Chemical synthesis and Combretastatin. His work carried out in the field of Cell culture brings together such families of science as Tubulin, Colchicine and Molecular biology.

He most often published in these fields:

  • Cancer research (50.00%)
  • Internal medicine (34.21%)
  • Cancer (29.74%)

What were the highlights of his more recent work (between 2016-2021)?

  • Cancer research (50.00%)
  • Internal medicine (34.21%)
  • Cancer (29.74%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Cancer research, Internal medicine, Cancer, Head and neck cancer and Cancer cell. His Cancer research research includes themes of Epithelial–mesenchymal transition, Carcinogenesis, Head and neck squamous-cell carcinoma, Transforming growth factor and Western blot. His research on Internal medicine frequently connects to adjacent areas such as Oncology.

The Cancer study combines topics in areas such as DNA damage, Angiogenesis, Drug resistance and Germline. The study incorporates disciplines such as Odds ratio, Alcohol, Confidence interval and Risk factor in addition to Head and neck cancer. His study looks at the relationship between Cancer cell and fields such as Cell, as well as how they intersect with chemical problems.

Between 2016 and 2021, his most popular works were:

  • New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment. (57 citations)
  • New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment. (57 citations)
  • Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells. (41 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Enzyme

His primary areas of study are Cancer research, Carcinogenesis, Immunology, Cancer cell and microRNA. His Cancer research research integrates issues from Cancer, Colorectal cancer, Lymphangiogenesis, Signal transduction and Tube formation. His studies deal with areas such as DNA damage, Angiogenesis, Drug resistance and Cisplatin as well as Cancer.

His Immunology study integrates concerns from other disciplines, such as ALDH2, Oral Microbiome and Oral hygiene. His Cancer cell research includes elements of CDC42, Cell migration, A549 cell and Cell biology. His microRNA research is multidisciplinary, relying on both DNMT3B, Retinoic acid, ALDH1A2, Gene silencing and Epigenetics.

Best Publications

  • New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment.

    Shang Hung Chen;Jang Yang Chang;Jang Yang Chang

  • BPR0L075, a Novel Synthetic Indole Compound with Antimitotic Activity in Human Cancer Cells, Exerts Effective Antitumoral Activity in Vivo

    Ching Chuan Kuo;Hsing Pang Hsieh;Wen Yu Pan;Ching Ping Chen

  • Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents.

    Jing Ping Liou;Yi Ling Chang;Fu Ming Kuo;Chun Wei Chang

  • Cytotoxic triterpenes from the aerial roots of Ficus microcarpa.

    Yi Ming Chiang;Jang-Yang Chang;Ching Chuan Kuo;Chi Yen Chang

  • Survivin - biology and potential as a therapeutic target in oncology.

    Chun Hei Antonio Cheung;Chien Chang Huang;Fang Ying Tsai;Jane Ying Chieh Lee

  • Novel Phosphoinositide 3-Kinase/mTOR Dual Inhibitor, NVP-BGT226, Displays Potent Growth-Inhibitory Activity against Human Head and Neck Cancer Cells In Vitro and In Vivo

    Kwang Yu Chang;Shan Yin Tsai;Ching Ming Wu;Chia Jui Yen

  • A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer

    J.S. Chen;C. Hsu;N.J. Chiang;N.J. Chiang;N.J. Chiang;C.S. Tsai

  • 2,2'-Diphenyl-1-picrylhydrazyl radical-scavenging active components from adlay (Coix lachryma-jobi L. var. ma-yuen Stapf) hulls.

    Ching Chuan Kuo;Wenchang Chiang;Guey Ping Liu;Ya Lin Chien

  • Downregulated miR329 and miR410 Promote the Proliferation and Invasion of Oral Squamous Cell Carcinoma by Targeting Wnt-7b

    Shine-Gwo Shiah;Shine-Gwo Shiah;Jenn-Ren Hsiao;Wei-Min Chang;Wei-Min Chang;Ya-Wen Chen

  • Epstein-Barr virus-associated gastric adenocarcinoma in Taiwan

    Horng Jyh Harn;Jang Yang Chang;Min Wei Wang;Li Ing Ho

  • Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells.

    Jang Yang Chang;Chi Yen Chang;Ching Chuan Kuo;Li Tzong Chen

  • Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents

    Jing Ping Liou;Jang Yang Chang;Chun Wei Chang;Chi Yen Chang

  • Antitumor agents. 111. New 4-hydroxylated and 4-halogenated anilino derivatives of 4'-demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase II.

    Kuo Hsiung Lee;Scott A. Beers;Masami Mori;Zhe Qing Wang

  • Aurora kinase inhibitors in preclinical and clinical testing

    Chun Hei Antonio Cheung;Mohane Selvaraj Coumar;Hsing Pang Hsieh;Jang Yang Chang

  • Mechanical regulation of cancer cell apoptosis and autophagy: roles of bone morphogenetic protein receptor, Smad1/5, and p38 MAPK.

    Sheng Chieh Lien;Shun Fu Chang;Pei Ling Lee;Shu Yi Wei

  • Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients.

    T. C. Chang;H. S. Shiah;C. H. Yang;K. H. Yeh

  • In vitro and in vivo studies of a novel potential anticancer agent of isochaihulactone on human lung cancer A549 cells

    Yi Lin Chen;Shinn Zong Lin;Jang Yang Chang;Yeung Leung Cheng

  • Characterization of camptothecin-resistant Chinese hamster lung cells.

    Jang Yang Chang;Lyle A. Dethlefsen;Lee R. Barley;Bing Sen Zhou

  • Recent Advances in Anti-Survivin Treatments for Cancer

    Rupinder K. Kanwar;C. H. Cheung;J. Y. Chang;Jagat R. Kanwar

  • Four New 6-Nor-5(6→7)abeo-abietane Type Diterpenes and Antitumoral Cytotoxic Diterpene Constituents from the Bark of Taiwania cryptomerioides

    Chi I. Chang;Jang Yang Chang;Ching Chuan Kuo;Wen Yu Pan

Frequent Co-Authors

Hsing-Pang Hsieh
Hsing-Pang Hsieh Academia Sinica
Yueh-Hsiung Kuo
Yueh-Hsiung Kuo China Medical University
Wu Chou Su
Wu Chou Su National Cheng Kung University
Ann-Lii Cheng
Ann-Lii Cheng National Taiwan University
Jacqueline Whang-Peng
Jacqueline Whang-Peng Taipei Medical University
Yung-Chi Cheng
Yung-Chi Cheng Yale University
Chun-Cheng Lin
Chun-Cheng Lin National Tsing Hua University
Michael Hsiao
Michael Hsiao Academia Sinica
Jagat R. Kanwar
Jagat R. Kanwar Deakin University
Ting-Chao Chou
Ting-Chao Chou Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

A background in Biology and Biochemistry opens doors to several advanced online degrees and career opportunities in healthcare and science. If you're interested in healthcare leadership, consider exploring the top online mha programs that are cahme accredited. These programs are highly regarded and can lead to roles in hospital administration or healthcare policy.

For those wanting to impact clinical practice at the highest level, online dnp programs without clinicals are an option to advance in nursing without the need for extensive in-person clinical hours. Similarly, individuals looking for executive or academic healthcare positions can pursue a doctorate in healthcare management online, which focuses on leadership, strategy, and policy skills within health organizations.

Those with a strong foundation in chemistry and life sciences might also consider an online pharmacy school. This pathway can lead to advanced roles in pharmacology, research, and clinical practice. Each of these online degree routes provides flexibility, making it easier to balance studies with personal and professional commitments while advancing your career in the life sciences.

Best Scientists Citing Jang Yang Chang

Trending Scientists

Recently Published Articles